Felix Zijlstra

Showing 1-20 of 21 articles

Validation of a three-dimensional quantitative coronary angiography-based software to calculate fractional flow reserve: the FAST study

Masdjedi K, van Zandvoort L, Balbi M, Gijsen F, Ligthart J, Rutten M, Lemmert M, Wilschut J, Diletti R, De Jaegere P, Zijlstra F, Van Mieghem N, Daemen J

September 18, 2020 | 10.4244/EIJ-D-19-00466

Incidence and predictors of outcomes after a first definite coronary stent thrombosis

Tovar Forero M, Zanchin T, Masdjedi K, van Zandvoort L, Kardys I, Zijlstra F, Häner J, Windecker S, Van Mieghem N, Räber L, Daemen J

July 17, 2020 | 10.4244/EIJ-D-19-00219

Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial

den Uil C, Van Mieghem N, Bastos M, Jewbali L, Lenzen M, Engstrom A, Bunge J, Brugts J, Manintveld O, Daemen J, Wilschut J, Zijlstra F, Constantinescu A

September 20, 2019 | 10.4244/EIJ-D-19-00254

Coronary interventions

New-generation mechanical circulatory support during high-risk PCI: a cross-sectional analysis

Ameloot K, Bastos M, Daemen J, Schreuder J, Boersma E, Zijlstra F, Van Mieghem N

August 29, 2019 | 10.4244/EIJ-D-18-01126

Other coronary interventions

Qualitative and quantitative evaluation of dynamic changes in non-culprit coronary atherosclerotic lesion morphology: a longitudinal OCT study

Zhang B-C, Karanasos A, Gnanadesigan M, van der Sijde J, van Ditzhuijzen N, Witberg K, Ligthart J, Diletti R, van Geuns R, Dijkstra J, Zijlstra F, van Soest G, Regar E

April 6, 2018 | 10.4244/EIJ-D-17-00161

Coronary interventions

Microvascular dysfunction following ST-elevation myocardial infarction and its recovery over time

Hassell M, Bax M, van Lavieren M, Nijveldt R, Hirsch A, Robbers L, Marques K, Tijssen J, Zijlstra F, van Rossum A, Delewi R, Piek J

August 4, 2017 | 10.4244/EIJ-D-16-00818

Coronary interventions

Stent overlap in acute myocardial infarction

Diletti R, Zijlstra F

August 4, 2017 | 10.4244/EIJV13I5A79

Coronary interventions

Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions

Fam J, Ojeda S, Garbo R, Latib A, La Manna A, Vaquerizo B, Boukhris M, Vlachojannis G, van Geuns R, Ezhumalai B, Kawamoto H, van der Sijde J, Felix C, Pan M, Serdoz R, Boccuzzi G, De Paolis M, Sardella G, Mancone M, Tamburino C, Smits P, Di Mario C, Seth A, Serra A, Colombo A, Serruys P, Galassi A, Zijlstra F, Van Mieghem N, Diletti R

June 20, 2017 | 10.4244/EIJ-D-16-00253

Coronary interventions

Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months

Felix C, Vlachojannis G, IJsselmuiden A, Fam J, Smits P, Lansink W, Diletti R, Zijlstra F, Regar E, Boersma E, Onuma Y, van Geuns R

June 2, 2017 | 10.4244/EIJ-D-17-00119

Coronary interventions

The long-term effect of transradial coronary catheterisation on upper limb function

van Leeuwen M, van der Heijden D, Hermie J, Lenzen M, Selles R, Ritt M, Kiemeneij F, Zijlstra F, Van Mieghem N, van Royen N

February 20, 2017 | 10.4244/EIJ-D-15-00395

Coronary interventions

Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries

Oemrawsingh R, Garcia-Garcia H, van Geuns R, Lenzen M, Simsek C, de Boer S, Van Mieghem N, Regar E, de Jaegere P, Akkerhuis K, Ligthart J, Zijlstra F, Serruys P, Boersma E

August 20, 2016

Coronary interventions

Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study

Fam J, Felix C, van Geuns R, Onuma Y, Van Mieghem N, Karanasos A, van der Sijde J, De Paolis M, Regar E, Valgimigli M, Daemen J, de Jaegere P, Zijlstra F, Diletti R

May 16, 2016 | 10.4244/EIJV12I1A6

Rapid exchange ultra-thin microcatheter using fibre-optic sensing technology for measurement of intracoronary fractional flow reserve

Diletti R, Van Mieghem N, Valgimigli M, Karanasos A, Everaert B, Daemen J, van Geuns R, de Jaegere P, Zijlstra F, Regar E

August 20, 2015 | 10.4244/EIJY15M05_09

Relation of genetic profile and novel circulating biomarkers with coronary plaque phenotype as determined by intravascular ultrasound: rationale and design of the ATHEROREMO-IVUS study

de Boer S, Cheng J, Garcia-Garcia H, Oemrawsingh R, van Geuns R, Regar E, Zijlstra F, Laaksonen R, Halperin E, Kleber M, Koenig W, Boersma E, Serruys P

December 22, 2014 | 10.4244/EIJV10I8A162

Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire – fractional flow reserve

Papafaklis M, Muramatsu T, Ishibashi Y, Lakkas L, Nakatani S, Bourantas C, Ligthart J, Onuma Y, Echavarría-Pinto M, Tsirka G, Kotsia A, Nikas D, Mogabgab O, van Geuns R, Naka K, Fotiadis D, Brilakis E, Garcia-Garcia H, Escaned J, Zijlstra F, Michalis L, Serruys P

September 28, 2014 | 10.4244/EIJY14M07_01

Percutaneous coronary interventions during ST-segment elevation myocardial infarction: current status and future perspectives

Diletti R, Yetgin T, Manintveld O, Ligthart J, Zivelonghi C, Zijlstra F, Ribichini F

August 19, 2014 | 10.4244/EIJV10STA4

An objective and reproducible method for quantification of aortic regurgitation after TAVI

Schultz C, Slots T, Yong G, Aben J, Van Mieghem N, Swaans M, Rahhab Z, Faquir N, van Geuns R, Mast G, Zijlstra F, de Jaegere P

July 21, 2014 | 10.4244/EIJY14M05_06

The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3)

Simsek C, Garcia-Garcia H, van Geuns R, Magro M, Girasis C, Van Mieghem N, Lenzen M, de Boer S, Regar E, van der Giessen WJ, Raichlen J, Duckers H, Zijlstra F, van der Steen A, Boersma E, Serruys P

June 27, 2012 | 10.4244/EIJV8I2A37

Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay

Heestermans A, de Boer M, van Werkum J, Mosterd A, Gosselink A, Dambrink J, van Houwelingen K, Koopmans P, Hamm C, Zijlstra F, ten Berg J, van’t Hof A

August 30, 2011 | 10.4244/EIJV7I4A73

Operator dependence of outcome after primary percutaneous coronary intervention

Vlaar P, de Smet B, van den Heuvel A, Anthonio R, Jessurun G, Tan E-S, Hillege H, Zijlstra F

January 20, 2011

Latest news

NEW ISSUE

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

EDITORIAL

Smoke signals – do they help to predict TAVI-associated stroke risk?

R. Kharbanda et al.

January 25, 2021

Trials Book

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Redo-TAVI, Major bleeding in the Amulet Observational Study, OCT findings in ESR...